%0 Journal Article
%T Precise theranostic nanomedicines for inhibiting vulnerable atherosclerotic plaque progression through regulation of vascular smooth muscle cell phenotype switching
%A Dong Han
%A Feng Cao
%A Jiangwei Chen
%A Jing Feng
%A Li Fan
%A Meiling Ding
%A Meng-Qi Xu
%A Miaomiao Fan
%A Sai Ma
%A Seyed Mohammad Motevalli
%A Weisheng Guo
%A Xing-Jie Liang
%A Ya Qiu
%A Yabin Wang
%J Theranostics
%D 2018
%I Ivyspring International Publisher
%R 10.7150/thno.24364
%X Coronary heart disease is a prevalent and fatal killer caused by vulnerable atherosclerotic plaques (VASPs). However, the precise detection and treatment of VASPs remains a difficult challenge. Here, we present the development of noninvasive human serum albumin (HSA)-based theranostic nanomedicines (NMs) for the specific diagnosis and effective therapy of VASPs.
%K atherosclerosis
%K theranostic nanomedicines
%K sirtuin 1
%K osteopontin
%K vascular smooth muscle cells
%U http://www.thno.org/v08p3693.htm